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Introduction
Over 70 yr ago, Warburg discovered that cancer cells are more 
dependent on glycolysis for generation of ATP, even when abun-
dant oxygen is present in the cellular environment (Warburg, 
1930). During the past several decades, this metabolic altera-
tion has been observed in many cancer types, including solid 
tumors and leukemia. It is now recognized that the Warburg 
effect represents a prominent metabolic characteristic of ma-
lignant cells. Although the exact mechanisms responsible for 
this metabolic alteration remain to be elucidated, malfunction 
of mitochondrial respiration or “respiration injury” due, in part, 
to mitochondrial DNA (mtDNA) mutations/deletions is thought 
to be an important contributing factor (Warburg, 1956; Wallace, 
1999; Simonnet et al., 2002; Xu et al., 2005). Recent studies 
revealed that cancer cells of various tissue origins exhibit fre-
quent mutations in their mtDNA (Carew et al., 2003; Copeland 
et al., 2002; Nomoto et al., 2002). Because mtDNA encodes for 
13 protein components of the mitochondrial respiratory chain, 
it is likely that certain mtDNA mutations may cause malfunction 
of the respiratory chain, forcing the cells to increase glycolysis 
to maintain their ATP supply. The active metabolism in cancer 
cells requires a constant supply of suffi  cient ATP. Paradoxically, 
generation of ATP through glycolysis (two ATPs per glucose) 
is far less effi  cient than ATP production through mitochon-
drial oxidative phosphorylation (36 ATPs per glucose). It is 
unclear how cancer cells, with this apparent disadvantage in en-
ergy metabolism, can survive the competition with other cells 
in vivo and develop as a malignant cell population with drug-
resistant potential.
Environmental factors, especially hypoxic conditions 
in the tumor tissue microenvironment, may also force cancer 
cells to use glycolytic pathways to generate ATP to meet their 
energy supply. Hypoxia-induced metabolic adaptations cause 
the hypoxic cells to exhibit certain biochemical characteristics 
similar to those of mitochondrial respiratory-defective cells. 
Under hypoxic conditions, cancer cells have to use the “energy-
ineffi  cient” glycolytic pathway to generate ATP, leading to 
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C
ancer cells exhibit increased glycolysis for ATP 
production due, in part, to respiration injury (the 
Warburg effect). Because ATP generation through 
glycolysis is less efﬁ  cient than through mitochondrial res-
piration, how cancer cells with this metabolic disadvan-
tage can survive the competition with other cells and 
eventually develop drug resistance is a long-standing 
  paradox. We report that mitochondrial respiration defects 
lead to activation of the Akt survival pathway through a 
novel mechanism mediated by NADH. Respiration-deﬁ  cient 
cells (ρ
-) harboring mitochondrial DNA deletion exhibit 
dependency on glycolysis, increased NADH, and ac-
tivation of Akt, leading to drug resistance and survival 
advantage in hypoxia. Similarly, chemical inhibition of 
mitochondrial respiration and hypoxia also activates Akt. 
The increase in NADH caused by respiratory deﬁ  ciency 
inactivates PTEN through a redox modiﬁ  cation  mecha-
nism, leading to Akt activation. These ﬁ  ndings  provide 
a novel mechanistic insight into the Warburg effect and 
explain how metabolic alteration in cancer cells may gain 
a survival advantage and withstand therapeutic agents.
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accumulation of a high level of NADH, which is normally 
channeled to the electron transport chain as the energy fuel in 
respiration-competent cells.
Cancer cells use multiple pathways to enhance their sur-
vival and prevent apoptosis under various conditions. Increased 
expression of Bcl-2 and -XL antiapoptotic factors and activation 
of NFκB and phosphatidylinositol 3-kinase (PI3K)–Akt path-
ways are among the well-characterized mechanisms by which 
cancer cells promote their survival capacity. Overexpression of 
Bcl-2 and/or -XL counteracts the proapoptotic effects of Bax and 
Bak and inhibits the mitochondria-mediated cell death pathway 
(Chan and Yu, 2004). NFκB can be activated by various stimuli, 
such as cytokines, DNA-damaging agents, and reactive oxygen 
species (ROS). Its antiapoptotic effect is mediated mainly by 
promoting expression of a variety of cell survival factors through 
a transcriptional activation mechanism (Aggarwal, 2004). The 
PI3K–Akt pathway promotes cell survival and proliferation 
through a series of downstream events, including enhancing 
  nutrient uptake and energy metabolism through activation of 
mTOR (Edinger and Thompson, 2002), stimulating aerobic 
  glycolysis (Elstrom et al., 2004), and suppressing apoptosis by 
phosphorylation of the Bad protein (Downward, 2004). The 
Akt survival pathway is positively and negatively regulated by 
PI3K and PTEN, respectively, through their opposing effects on 
 phosphatidylinositol-3′-phosphate (PIP3) generation (Stanbolic 
et al., 1998). Despite the fact that the regulatory mechanisms 
of these pathways have been characterized in great detail, their 
potential roles in promoting the survival of cancer cells with 
mitochondrial respiration defects remain largely unknown.
Because mitochondrial respiratory defects are frequently 
observed in human cancers, owing to genetic alterations of 
mtDNA and/or hypoxic conditions in tumor tissue environ-
ment, elucidation of the molecular and biochemical mecha-
nisms contributing to the survival of cancer cells with such 
metabolic defects is obviously important in understanding the 
biology of the Warburg effect and in developing new strategies 
to overcome drug resistance. This study used experimental 
model systems to investigate the possible survival mechanisms 
in cells with mitochondrial genetic defects and in mitochon-
drial respiration-competent cells under conditions where the 
  respiratory activity is compromised by specifi  c pharmacological 
inhibitors or by hypoxia.
Figure 1.  Biochemical and molecular charac-
terization of 𝗒
- cell clones. (A) Comparison of 
oxygen consumption by parental Raji cells and 
four ρ
- clones (C2, C6, C7, and C8). (B) Mito-
chondrial mass was determined by ﬂ  ow cytom-
etry analysis of Raji cells in comparison with a 
representative ρ
- clone (Raji-C2) using 60 nM 
MitoTracker Green. (C) Mitochondrial trans-
membrane potential (∆Ψm) in parental Raji 
cells and Raji-C2 cells by ﬂ  ow cytometry analy-
sis using 1 μM rhodamine-123. (D) Quantita-
tive comparison of mitochondrial mass and 
∆Ψm in Raji cells and four ρ
- clones. (E) Analy-
sis of mtDNA deletion in ρ
- clones. Total DNA 
isolated from Raji cells and all four ρ
- clones 
was subjected to PCR for the indicated mtDNA 
and nuclear gene regions, as described in 
  Materials and methods. Reaction products were 
analyzed on an agarose gel and visualized 
by ethidium staining. (F and G) Raji cells or 
Raji-C8 cells were seeded in semisolid medium 
(Immocult) and cultured under normoxia or 
  hypoxia conditions for colony formation, as 
described in Materials and methods. Data 
were from two separate experiments per-
formed in triplicate. (H) Comparison of the col-
ony formation ratio under hypoxia/normoxia 
in Raji cells and Raji-C8 cells. Colony forma-
tion ratio was determined by dividing the col-
ony formation efﬁ  ciency under hypoxia by that 
under normoxia conditions. (I) Raji cells and 
the ρ
- cells (Raji-C8) were seeded in semisolid 
medium and incubated at 37°C with 1.5% 
  oxygen for 2 wk. Colonies were stained and 
counted (data from two separate experiments 
performed in triplicate). Results are expressed 
as the mean ± the SD.MITOCHONDRIAL DEFECTS AND AKT ACTIVATION • PELICANO ET AL. 915
Results
Cancer cells with mitochondrial respiratory 
defects exhibit survival advantage
To investigate the molecular events contributing to the survival 
mechanisms in cancer cells with mitochondrial respiration de-
fects, we fi  rst derived multiple clones of respiration-defi  cient 
cells (ρ
-) with altered mtDNA from two different human cancer 
cell lines, HL-60 (leukemia), and Raji (lymphoma), and then 
examined potential molecular alterations that promote cell 
  survival. mtDNA was preferentially damaged using an established 
method, in which the respiration-competent parental cells were 
chronically exposed to a low concentration of ethidium bromide 
(50 ng/ml), and the resulting ρ
- cells were subcloned by a serial 
dilution method (King and Attardi, 1996; Pelicano et al., 2003). 
One subclone of ρ
- cells derived from HL-60 cells was desig-
nated as HL60-C6F cells, which have been previously charac-
terized (Pelicano et al., 2003). Four other ρ
- subclones (C2, C6, 
C7, and C8) were derived from Raji cells, and their alterations 
in mtDNA and mitochondrial functions are shown in Fig. 1. All 
ρ
- cells exhibited defects in respiration, as indicated by a lack of 
oxygen consumption (Fig. 1 A). However, the ρ
- cells still re-
tained their mitochondrial mass with apparently normal trans-
membrane potential (Fig. 1, B–D). PCR analysis of mtDNA 
revealed multiple deletions of mtDNA at ND1 and the D-loop 
regions (Fig. 1 E). The PCR products for COXII, ND4, and 
ATPase6 genes were reduced to various degrees in different ρ
- 
clones, suggesting possible reduction of these gene copy num-
bers or mutations in the mtDNA regions for the PCR primers, 
and thus retarded the PCR reactions. Interestingly, all ρ
- cells 
retained the cyt-b gene sequence at levels comparable to the 
parental cells. The nuclear gene GAPDH remained unchanged 
in all clones. The respiration-defi  cient phenotype of the ρ
- cells 
has been stable in long-term culture (over 20 mo) in medium 
without ethidium bromide.
All ρ
- cell clones derived from HL-60 and Raji cells were 
strictly dependent on glycolysis and required supplements of 
high glucose, pyruvate, and uridine for growth. Importantly, the 
ρ
- cells exhibited a better ability to grow in hypoxic conditions, 
a common situation cancer cells encounter in vivo. As illus-
trated in Fig. 1 F, under normoxia conditions, the parental Raji 
cells showed better colony-forming effi  ciency (CFE; 76%) than 
the respiration-defi  cient Raji-C8 clone (CFE 56%). However, 
under reduced oxygen conditions (5% O2), the respiration-
 defi  cient clone C8 showed a higher CFE compared with the 
  parental Raji cells (Fig. 1 G). We also noticed that the parental 
Raji cells formed larger colonies in normoxic conditions than in 
hypoxia, whereas the colony sizes of the Raji-C8 cells were 
similarly small both in hypoxia and normoxia. The colony for-
mation ratio under hypoxia/normoxia conditions showed that 
the Raji-C8 cells had a signifi  cant survival advantage under hy-
poxia compared with the parental cells (Fig. 1 H; P = 0.009). 
Similarly, when the cells were cultured under a more hypoxic 
condition (1.5% O2), the ρ
- C8 cells exhibited a higher colony 
formation rate than the parental Raji cells (Fig. 1 I).
Despite mitochondrial metabolic defects, ρ
- cells were not 
prone to drug-induced cell death, and exhibited reduced sensi-
tivity to common anticancer agents. As shown in Fig. 2 A, 
HL60-C6F cells were signifi  cantly less sensitive to arsenic tri-
oxide (As2O3) and taxol than the parental HL-60 cells, as mea-
sured by annexin-V reactivity. Similarly, the Raji ρ
- clones also 
showed less sensitivity to As2O3 (Fig. 2 B), doxorubicin (Fig. 2 C), 
and vincristine (Fig. 2 D). These fi  ndings suggest that the ρ
- cells 
appear to have some survival advantage. Because cell cycle and 
cell growing rates may also affect drug sensitivity, we compared 
the cell cycle profi  les of the ρ
- clones with their respective 
  parental cells (HL-60 and Raji). Analysis of cellular DNA con-
tents by fl  ow cytometry revealed no substantial difference in cell 
cycle distribution between the ρ
- clones and their parental cells 
(Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200512100/DC1). Although the ρ
- clones exhibited a moderate 
decrease in cell growth rate, they retained an active apoptotic 
response and showed massive cell death when incubated with 
the glycolytic inhibitor 3-bromopyruvate (Xu et al., 2005). 
Interestingly, the proapoptotic factor cytochrome c in the ρ
- cells 
Figure 2.  Comparison of parental HL-60 and Raji cells with the 𝗒
- clones 
for their apoptotic response to anticancer agents. (A) Quantitative analysis 
of apoptosis induced by 1 μg/ml As2O3 and 0.1 μM taxol for 24 h in 
  parental HL-60 cells (Par) and respiration-deﬁ  cient  ρ
- cells (HL60-C6F). 
Apoptosis was assayed by annexin-V/PI staining and quantitated by ﬂ  ow 
cytometry analysis (n = 4 separate assays). The respiration-deﬁ  cient HL60-
C6F cells were signiﬁ   cantly less sensitive to anticancer agents than the 
  parental cells (*, P < 0.05 compared with the parental HL-60 cells). (B–D) 
Comparison of parental Raji cells with four respiration-deﬁ  cient ρ
- cells for 
their apoptotic response to 1 μg/ml As2O3 for 24 h (B; n = 7), 0.1 μM 
doxorubicin for 36 h (C; n = 5), and 5 ng/ml vincristine for 36 h (D; n = 5). 
Apoptosis was assayed by annexin-V/PI staining and quantitated by 
ﬂ  ow cytometry analysis. Results are expressed as the mean ± the SD 
(*, P < 0.05 compared with the parental Raji cells).JCB • VOLUME 175 • NUMBER 6 • 2006  916
was comparable to the parental cells or even slightly increased 
(Fig. S1 B). Analysis of proteins extracts from mitochondrial 
and cytosolic fractions showed that cytochrome c was detected 
only in the mitochondrial fraction in both cell types (Fig. S1, 
C and D). Thus, the increased expression of this proapoptotic 
factor in ρ
- cells is confi   ned in the mitochondria, which is 
consistent with a previous observation (Li et al., 1995).
Activation of Akt 
in mitochondrial-deﬁ  cient cells
All four clones of ρ
- cells were then used for examination of 
changes in gene expression in comparison with their parental 
Raji cells, using oligonucleotide microarray produced at the 
University of Texas MD Anderson Cancer Center Genomic 
Core Facility. Among the genes that consistently exhibited 
changes in all four ρ
- clones, we identifi  ed two key molecules, 
PIK3CA and PTEN, involved in regulation of the Akt survival 
pathway. This suggested a possibility that Akt might be involved 
in promoting the survival of ρ
- cells. To determine whether Akt 
was indeed activated in the ρ
- cells, the expression of Akt pro-
tein level and its phosphorylation status were fi  rst assessed by 
immunoblotting. As shown in Fig. 3 A, Akt phosphorylation at 
both Ser-473 and Thr-308 increased in all ρ
- cells. The total Akt 
protein did not increase in HL60-C6F cells, and moderately in-
creased in the Raji ρ
- cells. Among the ρ
- clones, HL60-C6F, 
Raji-C2, -C6, and -C8 showed a signifi  cant increase in Akt 
phosphorylation, whereas only a slight increase was detected in 
Raji-C7 cells. Direct analysis of Akt enzyme activity in vitro 
using glycogen synthase kinase 3 (GSK-3) as the Akt substrate 
further confi  rmed the increase of Akt kinase activity in the 
ρ
- cells, albeit with some individual variation (Fig. 3 B). The 
reason for such variation among individual clones is likely 
caused by other changes induced by ethidium. To confi  rm that 
Akt activation is a general phenomenon in ρ
- cells, we analyzed 
an additional three ρ
- clones derived from HL-60 cells, and 
revealed that these ρ
- cells also exhibited a consistent increase 
of Akt activation (Fig. 3 C).
We then tested if the increase of Akt activation in ρ
- cells 
might be caused by an increased expression of PI3 kinase, 
which is a positive regulator of Akt. Western blot analysis 
showed that the protein expression of PI3Kp110α (catalytic 
subunit) and PI3Kp85 (regulatory subunit), as well as the tyro-
sine phosphorylation levels, were similar in the parental and 
ρ
- cells (unpublished data). Thus, Akt activation was unlikely 
because of an increase in PI3K. Because the phosphatase 
PTEN is a negative regulator of Akt pathway and the loss of 
PTEN activity has been correlated with increased Akt activity 
in cancer cells (Dahia et al., 1999), we compared the PTEN 
protein levels and its phosphorylation in ρ
- cells and their pa-
rental cells. PTEN protein and its phosphorylation at Ser-380 
and Thr-382/-383 were reduced in most ρ
- clones (Fig. 3 D). 
The PTEN protein and its phosphorylation state were inversely 
correlated with the degree of Akt phosphorylation (Fig. 3 A), 
which is consistent with the negative regulatory role of PTEN 
in Akt signaling.
We reasoned that if defi  ciency in mitochondrial respi-
ration was a key event that suppresses PTEN and causes Akt 
activation, inhibition of mitochondrial respiratory function in 
the parental cells should also cause PTEN suppression and Akt 
activation. To test this cause–effect relationship, we used rote-
none, a specifi  c inhibitor of the mitochondrial electron trans-
port complex I, to block respiration in Raji cells. At 100 nM, 
rotenone effectively blocked respiration as early as 5 min after 
drug exposure (Fig. 4 A), but did not cause signifi  cant cell death 
during a 24-h incubation, as assessed by annexin-V/propidium 
iodide (PI) staining (Fig. 4 B). Inhibition of respiration by 
rotenone caused a time-dependent activation of Akt, indicated 
by an increase in Akt phosphorylation, which elevated signifi  -
cantly at 3 h and remained active for at least 24 h (Fig. 4 C). 
Concurrently, there was a time-dependent decrease in phospho-
PTEN revealed by Western blotting using phospho-PTEN anti-
bodies (Fig. 4 D). These observations suggest that the inhibition 
of respiration by rotenone may either cause   dephosphorylation 
Figure 3.  The Akt pathway is constitutively activated in 𝗒
- cells. (A) Akt 
protein expression and its phosphorylation status were determined using 
anti-Akt and anti–phospho-Akt (Ser-473 and Thr-308) antibodies. The 
numbers below each lane indicate the relative density. (B) Comparison 
of in vitro kinase activity of protein extracts from ρ
- clones cells and the 
parental cells. Akt protein was ﬁ  rst immunoprecipitated with an anti-Akt 
antibody, and Akt enzyme activity was determined using an Akt kinase as-
say kit with GSK-3α/β fusion protein as the assay substrate, as described 
in Materials and methods. (C) Activation of Akt in ρ
- cells from HL-60. 
Akt protein expression and its active phosphorylation were determined 
using anti-Akt and anti–phospho-Akt (Ser-473) antibodies. Whole-cell 
extracts from the parental HL-60 cells and four ρ
- clones were prepared 
and subjected to immunoblotting analysis. (D) Reduced PTEN activity 
in the respiration-deﬁ  cient ρ
- clones. Expression of both activated PTEN 
(phosphorylated; phospho-PTEN) and total PTEN protein were determined 
using anti–phospho-PTEN antibodies (Ser-380 and Thr-382/383) and 
anti-PTEN antibody. The numbers below each lane show the relative band 
density normalized by β-actin. The value for the parental sample was 
expressed as 100%.MITOCHONDRIAL DEFECTS AND AKT ACTIVATION • PELICANO ET AL. 917
of PTEN, or mask the phosphorylated epitope. The overall 
PTEN protein appeared unchanged when respiration was 
acutely blocked. Consistently, other inhibitors of mitochondrial 
respiratory complexes, including antimycin A, cyanide, and 
oligomycin, also caused Akt activation (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200512100/DC1).
Because ROS are known to cause Akt activation, we 
tested the potential involvement of ROS in Akt activation when 
mitochondrial respiration was inhibited by rotenone. The 
addition of the antioxidant N-acetylcysteine (NAC) did not af-
fect rotenone-induced Akt activation, suggesting that ROS was 
not a major factor contributing to Akt activation in respiration-
suppressed cells (Fig. 4 E). Furthermore, analysis of superoxide 
in ρ
- cells showed that they contained lower basal levels of su-
peroxide than the parental cells (Fig. 4 F). Thus, these data sug-
gest that ROS may not be a critical mediator to activate Akt in 
cells lacking mitochondrial respiration. It should be noted, 
however, that exogenous ROS could induce Akt activation in 
Raji cells, as indicated by a signifi  cant Akt phosphorylation in 
the presence of 0.5 mM H2O2 (Fig. 4 H). As expected, the H2O2-
induced Akt activation could be suppressed by NAC (Fig. 4, 
G and H). This was different from the Akt activation in  respiration-
defi  cient cells.
NADH accumulation in respiration-deﬁ  cient 
cells leads to inactivation of PTEN
Because NADH is an essential substrate (electron donor) for the 
mitochondrial electron transport chain, defects in the respira-
tory chain function could lead to an accumulation of NADH. 
Indeed, chemical inhibition of respiration by rotenone caused 
a substantial increase in cellular NADH, from 81 to 130 arbitrary 
units (Fig. 5 A). Consistent with this observation, mitochondrial 
genetic defects also led to a signifi  cant increase of NADH in 
HL60-C6F cell and all ρ
- clones from Raji cells (Fig. 5 B). 
Interestingly, incubation of cell extracts from sonicated Raji 
cells with NADH (0.01–1 mM) in the presence of 1 mM ATP led 
to a signifi  cant increase in Akt phosphorylation without changing 
Akt protein levels (Fig. 5 C). Collectively, these observations 
suggest the possibility that the accumulation of NADH might 
be directly involved in Akt activation in the ρ
- cells.
Analysis of lactate (product of glycolysis) in culture 
medium showed that ρ
- cells produced signifi  cantly more  lactate 
(Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.
200512100/DC1). The lack of oxygen consumption and increased 
lactate accumulation in ρ
- cells indicate that the glycolytic path-
way is highly active in these cells. We speculated that the 
  increase in glycolysis for ATP generation in ρ
- cells might divert 
the glucose metabolic fl  ow away from the pentose phosphate 
pathway (PPP) and lead to a decrease of NADPH because PPP 
is the major pathway for NADPH generation. To test this possi-
bility, HPLC analysis was performed to determine the ratios of 
NADH/NADPH in ρ
- cells and parental cells. Under normal 
culture conditions, the ratios of NADH/NADPH in parental 
HL-60 and Raji cells were 0.50 and 0.36, respectively, suggesting 
an active NADPH generation in parental cells (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200512100/DC1). 
In contrast, all ρ
- clones exhibited reversed NADH/NADPH 
Figure 4.  Inhibition of mitochondrial respiration by rotenone led to Akt 
activation associated with PTEN inactivation. (A) Inhibition of respiration by 
rotenone in Raji cells. Cells were pretreated with 100 nM rotenone for 
5 min, and oxygen consumption was measured as an indication of mito-
chondrial respiration. (B) Treatment of Raji cells with 100 nM rotenone 
(Rot) for 24 h did not cause signiﬁ  cant apoptosis, as measured by annexin-
V/PI staining. (C) Time-dependent activation of Akt in Raji cells treated with 
100 nM rotenone for up to 24 h, and protein extracts were blotted using 
anti–phospho-Akt (Ser-473 and Thr-308) and anti-Akt antibodies. (D) Time-
dependent inactivation of PTEN in respiration-blocked Raji cells treated 
with rotenone. Raji cells were incubated with 100 nM rotenone for up to 
24 h as indicated, and protein extracts were blotted using anti–phospho-
PTEN (Ser-380/Thr-382/-383), anti-PTEN, and anti-β–actin antibodies. 
(E) Antioxidant NAC did not prevent Akt activation induced by rotenone. 
Raji cells were treated with 100 nM rotenone (Rot) for 24 h in the presence 
or absence of 5 mM NAC (added 60 min before rotenone). The protein 
extracts were blotted using anti–phospho-Akt (Ser-473) and anti-Akt anti-
bodies. (F) Comparison of superoxide (O2
-) content in parental Raji cells 
and ρ
- cells (Raji-C2 clone). Cellular O2
- was analyzed by ﬂ  ow cytometric 
analysis as previously described (Pelicano et al., 2003). (G) Raji cells were 
treated with 500 μM H2O2 for 1 h in the presence or absence of 5 mM 
NAC (added 60 min before H2O2). Cellular ROS was measured by ﬂ  ow 
cytometry using CM-H2DCFDA. (H) Activation of Akt by exogenous H2O2 
detected by Western blotting.JCB • VOLUME 175 • NUMBER 6 • 2006  918
ratios (1.41–2.46), which is consistent with the accumulation 
of NADH and the decrease in NADPH generation (Fig. S4 B).
To investigate the mechanism by which changes in cellu-
lar NADH and NADPH promote Akt activation, we tested the 
possibility that the increase in NADH/NADPH ratio might 
modify the redox status and function of PTEN, which is known 
to be redox-sensitive and dependent on NADPH/thioredoxin 
(Trx) to maintain its enzyme activity (Lee et al., 2002). Protein 
extracts from Raji cells were incubated with NADH, NADPH, 
Trx, or a combination of the three. The reaction products were 
divided into two portions for Western blot analysis under reduc-
ing and nonreducing conditions. As illustrated in Fig. 6 A, simi-
lar phospho-PTEN signals were detected in all samples under 
reducing condition, suggesting that there was no signifi  cant dif-
ference in PTEN phosphorylation. However, when the same 
samples were analyzed under nonreducing condition, striking 
differences in phospho-PTEN signals were observed. NADH 
caused a signifi  cant decrease of the phospho-PTEN signal de-
tectable under nonreducing condition (Fig. 6 A, lane 1), sug-
gesting that PTEN was likely in an oxidized state, which masked 
the epitope for antibody binding caused by disulfi  de bond for-
mation. Oxidation of PTEN by hydrogen peroxide has been 
shown to cause such a conformational change (Lee et al., 2002). 
Incubation of cell extracts with NADPH/Trx kept the PTEN 
protein in a reduced state, and the phosphoepitopes were readily 
detected (Fig. 6 A, lanes 2–3). Combination of NADPH and Trx 
also kept PTEN in a reduced state (Fig. 6 A, lane 5). Surprisingly, 
NADH + Trx did not reduce PTEN, and thus the accessibility 
to epitopes at Ser-380 and Thr-382/-383 was limited (Fig. 6 A, 
lane 4). These data suggest that NADH may compete with 
NADPH/Trx to affect the redox state of PTEN. To test this pos-
sibility, protein extracts were incubated with NADPH/Trx in the 
presence of various concentrations of NADH, and the accessi-
bility to epitopes at Ser-380 and Thr-382/-383 was determined 
under nonreducing conditions. As shown in Fig. 6 B, NADH 
competed with NADPH, and caused a concentration-dependent 
decrease of phospho-PTEN signal (lanes 3–5).
Figure 5.  Blockage of mitochondrial respiration caused an increase of 
cellular NADH and activation of Akt. (A) Inhibition of mitochondrial respi-
ration by rotenone (Rot) caused a substantial increase in cellular NADH. 
The parental Raji cells were treated with 100 nM rotenone for 2 h. 
Cellular NADH was determined by measuring the relative NADH ﬂ  uores-
cent intensity using ﬂ  ow cytometry analysis, as described in Materials and 
methods. (B) Quantiﬁ  cation of NADH levels in parental HL-60 and Raji 
cells in comparison with their respective ρ
- cell clones. (C) NADH en-
hanced Akt phosphorylation at Ser-473 in vitro. Protein lysates of Raji 
cells were prepared by sonication, as described in Materials and methods. 
The lysates containing cellular proteins and plasma lipid membranes were 
incubated for 20 min with the indicated concentrations of NADH and 
1 mM ATP. Akt phosphorylation and total Akt protein were assayed by 
Western blotting.
Figure 6.  Role of NADH in Akt activation through inactivation of PTEN 
by a redox-regulated mechanism. (A) Effect of NADH, NADPH, and Trx 
on the redox state of PTEN. Protein extracts were prepared from Raji cells 
by sonication, dialyzed with PBS for 60 min at 4°C, and then incubated 
with NADH, NADPH, and Trx in the presence of 1 mM ATP as indicated 
(37°C, 30 min). The redox status of PTEN was measured by assaying the 
accessibility of phosphorylated Ser-380 and Thr-382/383 epitopes by 
speciﬁ  c antibodies under reducing (2.5% β-mercaptoethanol in loading 
buffer, indicated by “R”) and nonreducing conditions (without β-mercap-
toethanol, indicated by “NR”). Oxidation of PTEN masks the epitopes be-
cause of the formation of an intramolecular disulﬁ  de bond, which was 
broken by β-mercaptoethanol. (B) Competition between NADH and 
NADPH and their effects on the redox status of PTEN. Protein lysates of 
Raji cells were incubated at 37°C for 30 min with NADH, NADPH, and 
Trx (10 μg/60 μl reaction) in the presence of 1 mM ATP. The redox status 
of PTEN was measured by Western blot analysis under nonreducing con-
dition, as described for A. The number below each lane indicates the rel-
ative density of the respective protein band normalized by β-actin. The 
relative band density of the reduced PTEN in the presence of NADPH and 
Trx (lane 2) is given an arbitrary value of 1. (C) Cellular localization of 
PTEN protein in Raji cells treated with or without 100 nM rotenone for 20 h 
and in Raji-C8 ρ
- cells. Cells were ﬁ  xed, immunostained for PTEN, and 
photographed, as described in Materials and methods. Arrows indicate 
the portion of PTEN protein associated with plasma membrane in paren-
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Fluorescent confocal microscopy analysis was then used 
to evaluate the localization of PTEN protein in Raji cells under 
various conditions. As illustrated in Fig. 6 C, a portion of the 
PTEN protein was localized in cellular membrane region under 
normal culture conditions. Incubation of Raji cells with rote-
none decreased the membrane localization of PTEN, which ex-
hibited defused intracellular distribution. The decrease in PTEN 
membrane localization was also observed in the respiration-
 defi  cient Raji-C8 cells (Fig. 6 C). These data suggest that mito-
chondrial defects or respiration inhibition could decrease PTEN 
membrane localization.
Akt activation in respiration-deﬁ  cient cells 
is PTEN dependent
To further evaluate the role of PTEN inactivation in mediating 
NADH-induced Akt activation, we used four cancer cell lines 
with either wild-type PTEN (HCT116 and LN-229 cells) or 
PTEN-null (Jurkat and U87-MG cells) and tested their Akt ac-
tivation in response to modulation of mitochondrial respiration. 
Incubation of HCT116 and LN-229 cells (wt PTEN) with rote-
none led to a time-dependent Akt activation, which was indi-
cated by an increase in Ser-473 phosphorylation (Fig. 7 A). In 
contrast, rotenone failed to further activate Akt in the PTEN-
null cell lines (Jurkat and U87-MG, Fig. 7 B). It should be 
noted that although Akt phosphorylation was constitutively 
high in the PTEN-null cells, Akt could still be further activated 
in these cells by other stimuli, such as TRAIL (Zauli et al., 
2005) and T cell antigen receptor stimulation with anti-CD3 
(Kwon et al., 2003).
Hypoxia is frequently seen in the tumor  microenvironment. 
Cancer cells under hypoxic conditions mainly use glycolysis 
to generate ATP and are metabolically similar to ρ
- cells. We 
further evaluate the role of PTEN inactivation in mediating 
Akt activation under hypoxic conditions. When HCT116 and 
LN-229 cells (wild-type PTEN) were incubated under hypoxic 
conditions, there was a signifi  cant increase in Akt activation as 
early as 2 h; this increase was indicated by increased phosphor-
ylation at Ser-473 (Fig. 7 C). In contrast, the PTEN-null cells 
(Jurkat and U87-GM) showed little change in their Akt phos-
phorylation (Fig. 7 D), further supporting the important role of 
PTEN in hypoxia-mediated Akt activation.
Inhibition of Akt activation sensitizes 
𝗒
- cells to anticancer agents
To evaluate the contribution of Akt activation to drug resistance 
in ρ
- cells, we tested the effect of inhibiting Akt pathway on 
drug-induced apoptosis in the ρ
- cells. Wortmannin, which is 
an inhibitor of the PI3K–Akt pathway, caused a concentration-
dependent decrease in Akt phosphorylation at Ser-473 and 
Thr-308 in HL60-C6F cells (Fig. 8 A). Wortmannin also caused 
dephosphorylation of Akt in all Raji ρ
- clones (Fig. 8 A). 
Another PI3K–Akt inhibitor, LY249002, produced similar 
 results (unpublished data). Inhibition of PI3K/Akt by wortmannin 
signifi  cantly increased the sensitivity of ρ
- cells to apoptosis 
induction by As2O3, as assessed by annexin-V reactivity (Fig. 
8 B) and cleavage of procaspase-3 (Fig. 8, C and D). We also 
used SH-6, which is a selective Akt inhibitor that does not 
affect the upstream kinases (Kozikowski et al., 2003), to further 
test sensitization of ρ
- cells. SH-6 was effective in enhancing 
apoptotic response to As2O3 in ρ
- cells (Fig. 8 E). Thus, inhi-
bition of the Akt pathway seems effective in enhancing the 
activity of anticancer agents against cancer cells with respiration 
defects. In contrast, inhibition of the mitochondrial ATP synthase 
(complex V) by oligomycin decreased cellular sensitivity to 
As2O3 and Taxol in parental HL-60 cells (Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200512100/DC1). 
Consistently, oligomycin did not signifi  cantly affect drug sen-
sitivity in ρ
- cells (HL60-C6F), which exhibited Akt activation 
and resistance to drug-induced apoptosis (Fig. S5). The insen-
sitivity of ρ
- cells to oligomycin is consistent with previous 
observations that the sensitivity of ATP-synthase (complex V) to 
oligomycin depends on the mitochondrial DNA-encoded sub-
unit 6 of F1-ATPase (Avner and Griffi  ths, 1973), and that cells 
lacking mtDNA possess normal levels of the nuclear DNA-
encoded α and β subunits of F1-ATPase, which is functional 
and sensitive to azide or aurovertin, but insensitive to oligomycin 
(Buchet and Godinot, 1998).
Discussion
Mitochondrial respiration malfunction and increased glycolysis 
are frequently observed in cancer cells. This metabolic alteration, 
known as the Warburg effect, is caused by complex biochemical 
Figure 7.  PTEN-dependent activation of Akt 
in whole cells by inhibition of mitochondrial 
respiration. (A and B) PTEN-dependent activa-
tion of Akt by rotenone in whole cells. The 
wild-type PTEN cells (HCT116 and LN-229) 
and PTEN-null cells (Jurkat and U87-MG) were 
incubated with 100 nM rotenone (Rot) for the 
indicated times, and Akt activation was mea-
sured by Western blot analysis of Ser-473 
phosphorylation. Total Akt was also blotted for 
comparison. (C and D) PTEN-dependent induc-
tion of Akt activation by hypoxia. The wild-type 
PTEN cells (HCT116 and LN-229) and PTEN-
null cells (Jurkat and U87-MG) were incubated 
under hypoxic conditions for the indicated 
times, and protein extracts were immediately 
prepared for analysis of total Akt protein and 
its phosphorylation at Ser-473, as described in 
Materials and methods.JCB • VOLUME 175 • NUMBER 6 • 2006  920
and molecular mechanisms. mtDNA mutations and tissue hy-
poxia represent genetic and environmental factors contributing 
to the Warburg effect. Cells defi  cient in respiration because of 
mtDNA alterations or hypoxic conditions are forced to produce 
ATP through glycolysis, which is much less effi  cient  than 
oxidative phosphorylation. Nevertheless, cancer cells manage 
to overcome such an apparent metabolic disadvantage, survive 
in vivo, and eventually emerge as a malignant cell population 
resistant to anticancer agents at the late stages of the disease 
progression. Thus, understanding the mechanisms underlying 
the increased survival capacity in cancer cells with compro-
mised mitochondrial respiratory function is an important 
research area.
Our study suggests that mitochondrial respiration defi  -
ciency leads to activation of the Akt survival pathway through 
NADH-mediated inactivation of PTEN. This is a novel mecha-
nism contributing to increased survival and drug resistance in 
cancer cells with compromised mitochondrial respiration. 
Several lines of evidences support this conclusion, as follows: 
(a) Cells that lack mitochondrial respiration because of mtDNA 
deletion, chemical inhibition of the electron transport chain, or 
exposure to hypoxia all exhibited signifi  cant Akt activation. 
(b) The cellular NADH/NADPH ratio abnormally increased 
when mitochondrial respiration was suppressed, and this was 
associated with a decrease in plasma membrane–associated 
PTEN. (c) Exogenous NADH led to inactivation of PTEN and 
activation of Akt in vitro. The inactivation of PTEN seems to be 
caused by redox modulation because NADH competed with 
NADPH/Trx to keep PTEN in an oxidized (inactive) state. 
These fi  ndings are consistent with previous studies showing in-
activation of PTEN by oxidation using hydrogen peroxide (Lee 
et al., 2002; Kwon et al., 2004). (d) Cells lacking functional 
PTEN did not respond to respiratory inhibition or hypoxia, and 
exhibited no further Akt activation, indicating the important 
role of PTEN in this process.
Under physiological conditions, NADH is generated 
through glycolysis and the tricarboxylic acid cycle, whereas 
NADPH is produced mainly via the PPP (shunt). The propor-
tion of glucose directed to each pathway is regulated by the 
  cellular energy metabolic state. Mitochondrial defects render 
cancer cells dependent on glycolysis for ATP supply, and the 
NADH generated from the tricarboxylic acid cycle is not used 
effectively because of the decrease in oxidative  phosphorylation. 
These metabolic alterations lead to an accumulation of NADH. 
At the same time, NADPH production from the PPP decreases 
because of increased utilization of glucose for glycolysis. 
Indeed, we consistently observed that the NADH/NADPH 
ratio was signifi  cantly increased in all eight clones of ρ
- cells 
(Fig. S4). Because NADH competes with NADPH and compro-
mises the ability of NADPH/Trx to keep PTEN in a reduced 
state, the metabolic changes in cancer cells with mitochondrial 
Figure 8.  Inhibition of PI3K–Akt pathway enhances drug sensitivity in 
respiration-deﬁ  cient  cells.  (A) Inhibition of Akt phosphorylation by 
  wortmannin in HL60-C6F cells and Raji ρ
- clones. Cells were incubated for 
24 h with the indicated concentrations of wortmannin (Wortm), and protein 
extracts were blotted using anti–phospho-Akt (Ser-473 and Thr-308) 
and anti-Akt antibodies. (B) Inhibition of PI3K–Akt pathway enhanced drug 
sensitivity in ρ
- cells. All ﬁ  ve ρ
- clones were pretreated with or without 
  wortmannin for 1 h and incubated with 1 μg/ml As2O3 for 24 h. Apoptotic 
cells were measured by ﬂ  ow cytometry analysis using annexin-V/PI staining. 
Results are the mean ± the SD of four separate experiments. (C) HL60-C6F 
cells were pretreated with or without 10 μM wortmannin for 1 h and incu-
bated with 1 μg/ml As2O3 for up to 24 h. Cell lysates were probed for 
pro–caspase-3 by immunoblotting. A decrease in pro–caspase-3 band in-
tensity indicates its cleavage during apoptosis. (D) Raji ρ
- cells (C2) were 
pretreated with or without 1 μM wortmannin for 1 h, and incubated with 
1 μg/ml As2O3 for up to 24 h. Cell lysates were probed for pro–caspase-3 
by immunoblotting. (E) Five clones of ρ
- cells were pretreated for 1 h with 
the Akt inhibitor SH-6, as indicated (3–20 μM), and incubated with 1 μg/ml 
As2O3 for 24 h. Apoptotic cells were then quantiﬁ  ed by ﬂ  ow cytometry 
analysis using annexin-V/PI staining. Results are the mean ± the SD of 
four separate experiments.MITOCHONDRIAL DEFECTS AND AKT ACTIVATION • PELICANO ET AL. 921
defects would lead to inactivation of PTEN and activation of 
Akt. Interestingly, NAC suppressed Akt activation induced by 
H2O2, but did not decrease rotenone-induced Akt phosphorylation. 
The likely explanation is that the redox-sensitive PTEN was 
inactivated when the ratio of NADH/NADPH was signifi  cantly 
increased. This elevated ratio could not be modulated by NAC 
when cells were treated with rotenone. In contrast, the anti-
oxidant NAC effectively decreased H2O2 and reduced its direct 
effect on PTEN.
The PI3K–Akt pathway is critical for cell survival 
(Cantley, 2002; Vivanco et al., 2002). Activation of PI3K results in 
generation of PIP3, which leads to activation of phosphoinositide-
dependent kinase-1 (PDK-1) and phosphorylation of Akt. In 
contrast, the lipid phosphatase PTEN removes a phosphate from 
PIP3, and thus acts as a negative regulator of Akt. Loss of PTEN 
leads to Akt activation in cancer cells (Wu et al., 1998). Thus, it 
is likely that oxidation of PTEN suppresses its phosphatase ac-
tivity and subsequently leads to Akt activation. Indeed, PTEN is 
sensitive to oxidative inactivation by H2O2 (Connor et al., 2005). 
The demonstration that respiration defects lead to activation of 
the Akt pathway caused by the accumulation of NADH and in-
activation of PTEN reveals a novel mechanism by which cancer 
cells survive under respiration-compromised conditions. Fig. 9 
illustrates a model of this cell survival mechanism. 
The degree of Akt activation among the ρ
- clones appeared 
somewhat heterogeneous. It is possible that during the process 
of establishing the ρ
- clones, the use of ethidium bromide to 
deplete mtDNA might also cause nuclear DNA mutations, 
which might affect PTEN function and/or Akt activation. This 
could also explain the heterogeneous colony formation effi  cien-
cies observed among the ρ
- clones. Although this heterogeneity 
refl  ects the complexity of the experimental systems, the con-
clusion that mitochondrial respiration defects lead to NADH-
mediated PTEN inactivation and Akt activation remains valid. 
This argument is supported by the observations that Akt activa-
tion was observed in all eight ρ
- clones, in cells treated with 
respiratory chain inhibitor rotenone, and in cells under hypoxia 
in a PTEN-dependent manner.
Because mitochondrial DNA mutations and hypoxia with 
subsequently increased glycolysis are prevalent in cancer 
cells (Polyak et al., 1998; Wallace, 1999; Fliss et al., 2000; 
Copeland et al., 2002; Gatenby and Gillies, 2004), activation 
of the Akt pathway through NADH-mediated PTEN inactiva-
tion is likely an important survival mechanism for cancer 
cells with such metabolic alterations. Additionally, the ability of 
Akt to promote glucose uptake may also contribute to cell 
survival (Rathmell et al., 2003). Interestingly, a recent study 
showed that Akt activation stimulates cells to use the glycolytic 
pathway to generate ATP (Elstrom et al., 2004). The observa-
tions that hypoxia caused Akt activation in both HCT116 and 
LN-229 cells and that respiratory-defi  cient cells exhibited 
certain growth advantage in hypoxia conditions further illus-
trate the clinical relevance of this mechanism in cancer cell 
survival and growth in vivo. Furthermore, if Akt activation is 
an important mechanism contributing to decreased drug sensi-
tivity associated with the Warburg effect, it is possible to over-
come such drug resistance by inhibition of Akt activation. 
In fact, our data suggest that this is possible. Further investiga-
tion is warranted to evaluate the clinical implications of this 
therapeutic strategy.
Materials and methods
Cell and cell culture
Human leukemia cells lines (HL-60 and Jurkat) and lymphoma cell line (Raji) 
were cultured in RPMI 1640 medium supplemented with 10% heat- inactivated 
FBS and 2 mM L-glutamine at 37°C with 5% CO2. Human malignant glioma 
cells (U87-MG and LN-229; S. Kondo, MD Anderson Cancer Center,   Houston, 
TX) were cultured in DMEM medium supplemented with 10% FBS and 2 mM 
L-glutamine. HCT116 human colon cancer cells from B. Vogelstein (Johns 
Hopkins University, Baltimore, MD) were cultured in McCoy’s 5A medium 
supplemented with 10% FBS and 2 mM L-glutamine. The respiration-deﬁ  cient 
ρ
- cells were established using an established method with ethidium bromide 
(King and Attardi, 1996), and maintained in RPMI 1640 medium containing 
0.47% glucose, 10% FBS, 2 mM L-glutamine, 50 μg/ml uridine, and 1 mM 
pyruvate without ethidium bromide as previously described (Pelicano et al., 
2003). To compare colony formation capacity under normoxia and hypoxia 
conditions, the parental Raji cells and the respiration-deﬁ  cient Raji-C8 cells 
were seeded onto 6-well plates (300 cells/well for normoxia and 400 cells/
well for hypoxia) in semisolid medium (MethoCult; StemCell Technologies, 
Inc.) containing 0.47% glucose, 10% FBS, 2 mM L-glutamine, 50 μg/ml 
  uridine, and 1 mM pyruvate, and incubated at 37°C under normoxia (21% 
oxygen) or hypoxia (1.5–5% oxygen) conditions for 2 wk. Colonies were 
stained, photographed, and counted.
Antibodies and reagents
The following antibodies were used for immunoblotting analyses using 
standard Western blotting procedures: phospho-Akt antibodies, anti–GSK-3, 
anti–phospho-GSK-3α/β, anti-PI3Kp110α, anti-PI3Kp85, anti–phospho-
Tyr of PI3Kp85, anti-PTEN, and phospho-PTEN antibodies (all purchased 
from Cell Signaling Technology); anti–β-actin (Sigma-Aldrich); anti-Akt1/2 
antibodies (Santa Cruz Biotechnology, Inc); anti–pro-caspase-3 (BD Bio-
sciences); LY294002, wortmannin, rotenone, NADH, NADPH, doxorubicin, 
taxol, As2O3, and vincristine (Sigma-Aldrich); SH-6 (AG Scientiﬁ  c, Inc.); 
Trx (Promega); MitoTracker Green, dihydroethidium, and rhodamine-123 
(Invitrogen); and Methocult H4230 (StemCell Technologies, Inc.).
Figure 9.  Schematic illustration of the mechanisms by which Akt is acti-
vated in cancer cells with mitochondrial respiration injury. Genetic factors 
(mtDNA mutations/deletions) and environmental factors (hypoxic condi-
tions) cause defects in mitochondrial respiration and render the cancer 
cells highly dependent on glycolysis for ATP generation. This metabolic al-
teration leads to an increase in NADH caused by the lack of its utilization 
by the respiratory chain and a decrease in NADPH from the PPP. The 
increased NADH effectively competes with NADPH and compromises the 
ability of NADPH/Trx to keep PTEN protein in the reduced state, leading 
to inactivation of PTEN and activation of Akt. The solid arrows indicate 
increased activity in the respective steps; the dashed arrows indicate 
decreased activity.JCB • VOLUME 175 • NUMBER 6 • 2006  922
Flow cytometry analysis of mitochondria mass, 𝖫𝖿m, NADH, 
and apoptosis
Cells were stained with 60 nM MitoTracker Green (60 min) to measure the 
mitochondrial mass, with 100 ng/ml dihydroethidium (60 min) to detect 
superoxide, or with 1 μM rhodamine-123 (60 min) to evaluate the mito-
chondrial transmembrane potential, as previously described (Pelicano 
et al., 2003). Analysis was performed using a FACScan ﬂ  ow cytometer 
(Becton Dickinson). A minimum of 10,000 cells per sample was analyzed. 
Cellular NADH was measured by quantifying its intrinsic ﬂ  uorescence under 
ultraviolet excitation, using a ﬂ   ow cytometer (LSR II; Becton Dickinson) 
equipped with a 325-nm excitation laser and a 440-nm centered band-
pass ﬁ  lter, as previously described (Robinson et al., 2000). To analyze 
drug-induced apoptosis, cells were stained with annexin-V–FITC and PI, or 
with a monoclonal FITC-conjugated antiactive caspase-3 antibody according 
to the manufacturer’s instruction (BD Biosciences). Data acquisition and 
analysis were performed using a FACScan ﬂ  ow cytometer with the Cell-
Quest software (BD Biosciences). Cells that were positively stained by annexin-
V–FITC only (early apoptosis) and positive for both annexin-V–FITC and PI 
(late apoptosis) were quantitated, and both subpopulations were consid-
ered as overall death cells.
Assays of Akt kinase activity and phosphorylation in vitro
The Akt enzyme activity was assayed using an Akt kinase kit according to 
the manufacturer’s directions (Cell Signaling Technology). To analyze the 
effect of NADH and NADPH on Akt activation in vitro, cell lysates were 
prepared by sonication. Raji cells were suspended in PBS containing a 
cocktail of protease inhibitors (Roche), sonicated on ice bath, and centri-
fuged in a refrigerated centrifuge (model 5415R; Eppendorf) at 10,000 rpm 
for 15 min to remove cell debris. Endogenous NADH and NADPH in 
the cell lysates were removed by dialysis in cold PBS containing protease 
inhibitors for 60 min. The cell lysates containing proteins and sonicated 
plasma lipid membranes were incubated for 20 min with NADH, NADPH, 
and ATP as speciﬁ  ed in the ﬁ  gure legends. Akt phosphorylation at Ser-473 
and total Akt protein were assayed by Western blotting.
Measurement of respiration activity
Oxygen consumption in intact cells was measured as an indication of mito-
chondrial respiration activity. Cells (5 × 10
6) were suspended in 1 ml of 
culture medium preequilibrated with 21% oxygen; then they were placed 
in a sealed respiration chamber to monitor oxygen consumption, as previ-
ously described (Pelicano et al., 2003).
PCR analysis of mtDNA
Total DNA containing nuclear and mitochondrial DNA was isolated from 
3 × 10
6 cells, as previously described (Carew et al., 2003). The nucleotide 
sequences of the PCR primers for mitochondrial D loop (15–484), NDI 
(3,304–3,836), COXII (7,645–8,215), ATPase 6 (8,539–9,059), ND4 
(11,403–11,927), Cytochrome b (15,260–15,774), and GAPDH, and 
the PCR reaction conditions were previously described (Carew et al., 
2003). The PCR products were analyzed by electrophoresis on a 1.2% 
Agarose gel, stained with ethidium bromide, and photographed.
Measurement of intracellular NADH and NADPH by HPLC
The parental cells (HL-60 and Raji) and ρ
- cells in exponentially growing 
phase were washed twice with PBS, and NADH and NADPH were ex-
tracted using 0.4 N HClO4, followed by neutralization with concentrated 
KOH. The neutralized cell extracts were immediately analyzed for NADH 
and NADPH, using a HPLC method adapted from previously described pro-
cedures (Reiss et al., 1984). In brief, NADH/NADPH standards or cell 
  extracts (550 μl; equivalent to 5.5 × 10
6 cells) were applied to an 
anion-exchange column (Partisil-10 SAX; Whatman) and run at a ﬂ  ow rate 
of 1.5 ml/min using a concave gradient (curve #9) from 100% buffer A 
(5 mM NaH2PO4, pH 4.0) to 100% buffer B (250 mM NaH2PO4 + 0.5 M 
NaCl, pH 4.75) over 15 min, followed by another 15-min isocratic 100% 
buffer B, using a HPLC system (Waters Alliance) equipped with Empower 
Software. NADH and NADPH were detected by their UV absorbance at 
340 nm, with retention times of 17.1 and 20.1 min, respectively, under 
these conditions. Because auto-oxidation of NADH and NADPH in the sam-
ples can decrease the UV absorbance at 340 nm, HPLC analysis was per-
formed immediately after cell extracts were prepared. To minimize the 
potential effect of auto-oxidation on quantitation, the ratio of NADH/NADPH 
was calculated from the peak areas of NADH and NADPH of the same 
HPLC chromatograms. This ratio did not change when the same sample was 
injected at different times. This normalization allows a quantitative comparison 
of NADH/NADPH ratios between the parental cells and the ρ
- clones.
Immunoﬂ  uorescence cytochemistry and confocal microscopy
Cells were cytospun onto poly-L-lysine–coated glass slides using a cytospin 
(Shandon-Elliot) and were immediately ﬁ  xed with 100% acetone for 5 min. 
After blocking in PBS containing 1% BSA, the samples were stained with 
anti-PTEN mouse monoclonal antibody for 1 h (clone PTEN-18; Sigma-
  Aldrich), followed by a 1-h incubation with Texas red–conjugated anti–
mouse secondary antibody (Vector Laboratories; 1:300). The cells were 
visualized using a laser scanning confocal microscope (FluoView 500; 
Olympus). Images were captured using a 60× objective with proper ﬁ  lter 
sets (model IX71FVSF-2; Olympus).
Statistical analysis
A t-test was used to evaluate the statistical differences of the experimental 
values between two samples to be compared.
Online supplemental material
Fig. S1 shows the comparison of cell cycle proﬁ  les and cytochrome c ex-
pression in ρ
- clones and their parental cells. Fig. S2 shows the activation 
of Akt in Raji cells treated with respiratory chain inhibitors. Fig. S3 shows 
the lactate production in ρ
- cells in comparison with their parental cells 
(HL-60 and Raji). Fig. S4 shows the comparison of NADH/NADPH ratios 
in parental HL-60 and Raji cells and respiration-deﬁ  cient cell clones. Fig. S5 
shows the effect of oligomycin on cellular sensitivity to taxol and As2O3 in 
HL-60 cells and HL-60–C6F cells. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200512100/DC1.
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